NCT05702905: Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
- State
- State not given
- Phase
- Phase 4
- People
- 75 planned
- Started
- 9 May 2023
- Primary completion
- 31 Dec 2024
- Arms
- semaglutide and metformin
- Results
- None posted
- Papers
- doi:10.1007/bf03401383, doi:10.1007/s00404-022-06700-3, doi:10.1007/s40618-021-01666-6, doi:10.1016/j.rbmo.2019.04.017, doi:10.1097/cm9.0000000000001712, doi:10.1111/cen.13454, doi:10.1210/clinem/dgaa285, doi:10.1530/eje-13-0797, doi:10.1530/eje-18-0175, doi:10.17219/acem/151695, doi:10.3389/fendo.2022.945609
- 27 Jan 2023: Trial registered
- 9 May 2023: Trial started